Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds REPLREPLIMUNE GROUP

13 funds on our shelf carry REPLIMUNE GROUP — heaviest hand: DWAS at 1.99% of its book.

FundWeightFund assetsShares held
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX1.99%$411M351,816
BBCVirtus Biotech Clinical Trials ETF1.92%—28,183
CANCTema Oncology ETF1.19%—114,629
XBIState Street SPDR S&P Biotech ETFINDEX0.55%$10.3B2,567,389
IWCiShares Micro-Cap ETFINDEX0.45%$1.3B245,048
OPTZOptimize Strategy Index ETFINDEX0.27%$148M32,134
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.13%$112M7,926
IBBiShares Biotechnology ETFINDEX0.13%$10.6B667,459
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.12%$624M95,374
PWSPacer WealthShield ETFACTIVE0.11%$20M790
VFMOVanguard U.S. Momentum Factor ETFINDEX0.09%$646M130,101
BIBProShares Ultra Nasdaq BiotechnologyINDEX0.09%$92M3,955
VHTVanguard Health Care Index FundINDEX0.01%$19B173,918

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.